Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Exploring healthcare professionals' knowledge, attitudes and experiences of shared decision making in rheumatology.

Mathijssen EGE, van den Bemt BJF, Wielsma S, van den Hoogen FHJ, Vriezekolk JE.

RMD Open. 2020 Jan;6(1). pii: e001121. doi: 10.1136/rmdopen-2019-001121.

PMID:
31958279
2.

Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial.

Michielsens CAJ, Boers N, den Broeder N, Wenink MH, van der Maas A, Mahler EAM, Mulder MLM, van der Heijde D, van den Hoogen FHJ, Verhoef LM, den Broeder AA.

Trials. 2020 Jan 15;21(1):90. doi: 10.1186/s13063-019-4000-5.

3.

Comparison of physical activity among different subsets of patients with knee or hip osteoarthritis and the general population.

Pelle T, Claassen AAOM, Meessen JMTA, Peter WF, Vliet Vlieland TPM, Bevers K, van der Palen J, van den Hoogen FHJ, van den Ende CHM.

Rheumatol Int. 2020 Jan 7. doi: 10.1007/s00296-019-04507-1. [Epub ahead of print]

PMID:
31912266
4.

An Electronic Health Tool to Prepare for the First Orthopedic Consultation: Use and Usability Study.

Claassen AAOM, Vliet Vlieland TPM, Busch VJJF, Schers HJ, van den Hoogen FHJ, van den Ende CHM.

JMIR Form Res. 2019 Nov 28;3(4):e13577. doi: 10.2196/13577.

5.

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis.

Kersten BE, den Broeder N, van den Hoogen FHJ, Knaapen-Hans HAK, van den Ende CHM, Vonk MC.

Rheumatology (Oxford). 2019 Oct 19. pii: kez487. doi: 10.1093/rheumatology/kez487. [Epub ahead of print]

PMID:
31628802
6.

Office-based CO2 laser surgery for benign and premalignant laryngeal lesions.

Wellenstein DJ, Honings J, Schimberg AS, Schutte HW, Herruer JM, van den Hoogen FJA, Takes RP, van den Broek GB.

Laryngoscope. 2019 Sep 9. doi: 10.1002/lary.28278. [Epub ahead of print]

PMID:
31498454
7.

Interventions to support shared decision making for medication therapy in long term conditions: A systematic review.

Mathijssen EGE, van den Bemt BJF, van den Hoogen FHJ, Popa CD, Vriezekolk JE.

Patient Educ Couns. 2019 Aug 28. pii: S0738-3991(19)30376-3. doi: 10.1016/j.pec.2019.08.034. [Epub ahead of print] Review.

PMID:
31493959
8.

Office-based vs. operating room-performed laryngopharyngeal surgery: a review of cost differences.

Schimberg AS, Wellenstein DJ, van den Broek EM, Honings J, van den Hoogen FJA, Marres HAM, Takes RP, van den Broek GB.

Eur Arch Otorhinolaryngol. 2019 Nov;276(11):2963-2973. doi: 10.1007/s00405-019-05617-z. Epub 2019 Sep 5. Review.

9.

Development and evaluation of a tailored e-self-management intervention (dr. Bart app) for knee and/or hip osteoarthritis: study protocol.

Pelle T, Bevers K, van der Palen J, van den Hoogen FHJ, van den Ende CHM.

BMC Musculoskelet Disord. 2019 Aug 31;20(1):398. doi: 10.1186/s12891-019-2768-9.

10.

What moves the rheumatologist? Unravelling decision making in the referral of systemic sclerosis patients to health professionals: a qualitative study.

Stöcker JK, Cup EHC, Vonk MC, van den Hoogen FHJ, Nijhuis-van der Sanden MWG, Staal JB, van den Ende CHM.

Rheumatol Adv Pract. 2018 Aug 22;2(2):rky027. doi: 10.1093/rap/rky027. eCollection 2018.

11.

Implementing Psoriatic Arthritis Disease Activity Score-guided treat-to-target in psoriatic arthritis routine clinical practice: (im)possible?

Mulder MLM, den Broeder AA, van Ginneken BTJ, Mahler EAM, van den Hoogen FHJ, Vriezekolk JE, Wenink MH.

Rheumatology (Oxford). 2019 Dec 1;58(12):2330-2331. doi: 10.1093/rheumatology/kez254. No abstract available.

PMID:
31230083
12.

Cost-effectiveness of five different anti-tumour necrosis factor tapering strategies in rheumatoid arthritis: a modelling study.

Verhoef LM, Bos D, van den Ende C, van den Hoogen F, Fautrel B, Hulscher ME, Kievit W, den Broeder AA.

Scand J Rheumatol. 2019 Nov;48(6):439-447. doi: 10.1080/03009742.2019.1613674. Epub 2019 Jun 21.

PMID:
31220991
13.

Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Kwakkenbos L, Thombs BD, Khanna D, Carrier ME, Baron M, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mayes MD, Mouthon L, Nielson WR, Poiraudeau S, Riggs R, Sauvé M, Wigley F, Hudson M, Bartlett SJ.

Rheumatology (Oxford). 2019 Jun 5. pii: kez234. doi: 10.1093/rheumatology/kez234. [Epub ahead of print] No abstract available.

PMID:
31168593
14.

Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.

Verhoef LM, van den Bemt BJ, van der Maas A, Vriezekolk JE, Hulscher ME, van den Hoogen FH, Jacobs WC, van Herwaarden N, den Broeder AA.

Cochrane Database Syst Rev. 2019 May 24;5:CD010455. doi: 10.1002/14651858.CD010455.pub3.

PMID:
31125448
15.

Unsuccessful submandibular duct surgery for anterior drooling: Surgical failure or parotid gland salivation?

Delsing CPA, Bekkers S, van Hulst K, Erasmus CE, van den Hoogen FJA.

Int J Pediatr Otorhinolaryngol. 2019 Aug;123:132-137. doi: 10.1016/j.ijporl.2019.04.036. Epub 2019 Apr 30.

PMID:
31102967
16.

Novel Treatment Option for a Lateral Pharyngeal Diverticulum.

Phijffer EWEM, Bekkers S, van den Hoogen FJA.

Ear Nose Throat J. 2019 Apr 8:145561319841206. doi: 10.1177/0145561319841206. [Epub ahead of print] No abstract available.

PMID:
30961376
17.

Submandibular gland botulinum neurotoxin A injection for predicting the outcome of submandibular duct relocation in drooling: a retrospective cohort study.

Kok SE, van Valenberg HFJP, van Hulst K, Jongerius P, Erasmus CE, van den Hoogen FJA.

Dev Med Child Neurol. 2019 Nov;61(11):1323-1328. doi: 10.1111/dmcn.14199. Epub 2019 Mar 10.

PMID:
30854648
18.

Cost analysis of office-based transnasal esophagoscopy.

Wellenstein DJ, Honings J, Schutte HW, Herruer JM, van den Hoogen FJA, Marres HAM, Takes RP, van den Broek GB.

Eur Arch Otorhinolaryngol. 2019 May;276(5):1457-1463. doi: 10.1007/s00405-019-05357-0. Epub 2019 Feb 26.

19.

Predictive value of ex-vivo drug-inhibited cytokine production for clinical response to biologic DMARD therapy in rheumatoid arthritis.

Tweehuysen L, den Broeder AA, Schraa K, Netea MG, van den Hoogen FHJ, Joosten LAB.

Clin Exp Rheumatol. 2019 May-Jun;37(3):367-372. Epub 2019 Feb 7.

PMID:
30767874
20.

Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities.

Bekkers S, Delsing CP, Kok SE, van Hulst K, Erasmus CE, Scheffer ART, van den Hoogen FJA.

Neurology. 2019 Mar 12;92(11):e1195-e1204. doi: 10.1212/WNL.0000000000007081. Epub 2019 Feb 6.

PMID:
30728311
21.

Yes, it is time to redefine the role of low-dose radiation therapy for benign diseases! Response to Letter by Montero et al.

Mahler EAM, Minten MJ, Leseman-Hoogenboom MM, Poortmans PMP, Leer JW, Boks SS, van den Hoogen FHJ, den Broeder AA, van den Ende CH.

Ann Rheum Dis. 2019 Feb 1. pii: annrheumdis-2018-214896. doi: 10.1136/annrheumdis-2018-214896. [Epub ahead of print] No abstract available.

PMID:
30709815
22.

Response to: 'Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis' by Wu et al.

Mahler EAM, Minten MJM, Leseman-Hoogenboom MM, Poortmans PMP, Leer JWH, Boks SS, van den Hoogen FHJ, den Broeder AA, van den Ende CH.

Ann Rheum Dis. 2019 Jan 4. pii: annrheumdis-2018-214795. doi: 10.1136/annrheumdis-2018-214795. [Epub ahead of print] No abstract available.

PMID:
30610062
23.

Unraveling SSc Pathophysiology; The Myofibroblast.

van Caam A, Vonk M, van den Hoogen F, van Lent P, van der Kraan P.

Front Immunol. 2018 Nov 13;9:2452. doi: 10.3389/fimmu.2018.02452. eCollection 2018. Review.

24.

Exploring longitudinal associations of histologically assessed inflammation with symptoms and radiographic damage in knee osteoarthritis: combined results of three prospective cohort studies.

Minten MJM, Blom A, Snijders GF, Kloppenburg M, van den Hoogen FHJ, den Broeder AA, van der Kraan PM, van den Ende CHM.

Osteoarthritis Cartilage. 2019 Jan;27(1):71-79. doi: 10.1016/j.joca.2018.10.014. Epub 2018 Nov 16.

25.

Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.

Arntz OJ, Pieters BCH, Thurlings RM, Wenink MH, van Lent PLEM, Koenders MI, van den Hoogen FHJ, van der Kraan PM, van de Loo FAJ.

Front Immunol. 2018 Oct 29;9:2388. doi: 10.3389/fimmu.2018.02388. eCollection 2018.

26.

Emergency front-of-neck airway by ENT surgeons and residents: A dutch national survey.

Bruijstens L, Titulaer I, Scheffer GJ, Steegers M, van den Hoogen F.

Laryngoscope Investig Otolaryngol. 2018 Oct 31;3(5):356-363. doi: 10.1002/lio2.183. eCollection 2018 Oct.

27.

Systemic sclerosis: state of the art on clinical practice guidelines.

Smith V, Scirè CA, Talarico R, Airo P, Alexander T, Allanore Y, Bruni C, Codullo V, Dalm V, De Vries-Bouwstra J, Della Rossa A, Distler O, Galetti I, Launay D, Lepri G, Mathian A, Mouthon L, Ruaro B, Sulli A, Tincani A, Vandecasteele E, Vanhaecke A, Vanthuyne M, Van den Hoogen F, Van Vollenhoven R, Voskuyl AE, Zanatta E, Bombardieri S, Burmester G, Eurico FJ, Frank C, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, van Laar JM, Vieira A, Cutolo M, Mosca M, Matucci-Cerinic M.

RMD Open. 2018 Oct 18;4(Suppl 1):e000782. doi: 10.1136/rmdopen-2018-000782. eCollection 2018.

28.

Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis: a randomised, double-blinded, sham-controlled trial.

Mahler EAM, Minten MJ, Leseman-Hoogenboom MM, Poortmans PMP, Leer JWH, Boks SS, van den Hoogen FHJ, den Broeder AA, van den Ende CHM.

Ann Rheum Dis. 2019 Jan;78(1):83-90. doi: 10.1136/annrheumdis-2018-214104. Epub 2018 Oct 26.

PMID:
30366945
29.

Short-term clinical worsening is a clear predictor for worsening at 2 years in established knee and hip osteoarthritis.

Mahler EAM, den Broeder AA, den Broeder N, Bijlsma JWJ, Snijders GF, van den Hoogen FHJ, van den Ende CHM.

Clin Exp Rheumatol. 2019 May-Jun;37(3):414-421. Epub 2018 Sep 17.

PMID:
30299244
30.

Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent.

Kristensen LE, Alten R, Puig L, Philipp S, Kvien TK, Mangues MA, van den Hoogen F, Pavelka K, Vulto AG.

BioDrugs. 2018 Oct;32(5):397-404. doi: 10.1007/s40259-018-0306-1.

31.

Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial.

Minten MJM, Leseman-Hoogenboom MM, Kloppenburg M, Kortekaas MC, Leer JW, Poortmans PMP, van den Hoogen FHJ, den Broeder AA, van den Ende CHM.

Osteoarthritis Cartilage. 2018 Oct;26(10):1283-1290. doi: 10.1016/j.joca.2018.06.010. Epub 2018 Jul 7.

32.

Digital Video Laryngoscopy and Flexible Endoscopic Biopsies as an Alternative Diagnostic Workup in Laryngopharyngeal Cancer: A Prospective Clinical Study.

Schutte HW, Takes RP, Slootweg PJ, Arts MJPA, Honings J, van den Hoogen FJA, Marres HAM, van den Broek GB.

Ann Otol Rhinol Laryngol. 2018 Nov;127(11):770-776. doi: 10.1177/0003489418793987. Epub 2018 Sep 7.

PMID:
30192647
33.

Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key.

den Broeder N, Bouman CAM, Kievit W, van Herwaarden N, van den Hoogen FHJ, van Vollenhoven RF, Bijlsma HWJ, van der Maas A, den Broeder AA.

Ann Rheum Dis. 2019 Jan;78(1):141-142. doi: 10.1136/annrheumdis-2018-213547. Epub 2018 Aug 27. No abstract available.

PMID:
30150367
34.

Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial.

van den Hombergh WMT, Kersten BE, Knaapen-Hans HKA, Thurlings RM, van der Kraan PM, van den Hoogen FHJ, Fransen J, Vonk MC.

Trials. 2018 Aug 22;19(1):449. doi: 10.1186/s13063-018-2798-x.

35.

Most Important Frequently Asked Questions From Patients With Hip or Knee Osteoarthritis: A Best-Worst Scaling Exercise.

Claassen AAOM, Kremers-van de Hei KCALC, van den Hoogen FHJ, van der Laan WH, Rijnen WHC, Koëter S, Botman J, Busch VJJF, Schers HJ, van den Ende CHM.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):885-892. doi: 10.1002/acr.23719. Epub 2019 May 21.

PMID:
30055092
36.

Topical Anesthesia for Endoscopic Office-based Procedures of the Upper Aerodigestive Tract.

Wellenstein DJ, van der Wal RAB, Schutte HW, Honings J, van den Hoogen FJA, Marres HAM, Takes RP, van den Broek GB.

J Voice. 2019 Sep;33(5):732-746. doi: 10.1016/j.jvoice.2018.02.006. Epub 2018 Jul 13. Review.

PMID:
30017430
37.

The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study.

Verhoef LM, Selten EMH, Vriezekolk JE, de Jong AJL, van den Hoogen FHJ, den Broeder AA, Hulscher ME.

Rheumatology (Oxford). 2018 Nov 1;57(11):1947-1955. doi: 10.1093/rheumatology/key205.

PMID:
30010899
38.

Effectiveness of submandibular duct relocation in 91 children with excessive drooling: A prospective cohort study.

Kok SE, Erasmus CE, Scheffer ART, van Hulst K, Rovers MM, van den Hoogen FJA.

Clin Otolaryngol. 2018 Dec;43(6):1471-1477. doi: 10.1111/coa.13188. Epub 2018 Aug 9.

PMID:
29989346
39.

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function.

van den Hombergh WMT, Simons SO, Teesselink E, Knaapen-Hans HKA, van den Hoogen FHJ, Fransen J, Vonk MC.

Clin Rheumatol. 2018 Oct;37(10):2715-2722. doi: 10.1007/s10067-018-4171-6. Epub 2018 Jul 10.

40.

The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.

Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauvé M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larché M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD; SPIN Investigators.

Rheumatology (Oxford). 2018 Sep 1;57(9):1623-1631. doi: 10.1093/rheumatology/key139.

PMID:
29868924
41.

Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis.

Tweehuysen L, den Broeder N, van Herwaarden N, Joosten LAB, van Lent PL, Vogl T, van den Hoogen FHJ, Thurlings RM, den Broeder AA.

RMD Open. 2018 Apr 9;4(1):e000654. doi: 10.1136/rmdopen-2018-000654. eCollection 2018.

42.

Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study.

Tweehuysen L, Huiskes VJB, van den Bemt BJF, Vriezekolk JE, Teerenstra S, van den Hoogen FHJ, van den Ende CH, den Broeder AA.

Arthritis Rheumatol. 2018 Sep;70(9):1408-1418. doi: 10.1002/art.40516. Epub 2018 Aug 6.

43.

Support needs for medication use and the suitability of eHealth technologies to address these needs: a focus group study of older patients with rheumatoid arthritis.

Mathijssen EG, Vriezekolk JE, Eijsbouts AM, van den Hoogen FH, van den Bemt BJ.

Patient Prefer Adherence. 2018 Mar 7;12:349-358. doi: 10.2147/PPA.S152759. eCollection 2018.

44.

Development of the Drooling Infants and Preschoolers Scale (DRIPS) and reference charts for monitoring saliva control in children aged 0-4 years.

van Hulst K, van den Engel-Hoek L, Geurts ACH, Jongerius PH, van der Burg JJW, Feuth T, van den Hoogen FJA, Erasmus CE.

Infant Behav Dev. 2018 Feb;50:247-256. doi: 10.1016/j.infbeh.2018.01.004. Epub 2018 Feb 12.

PMID:
29448187
45.

Ex vivo inhibited cytokine profiling may explain inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis.

Tweehuysen L, Schraa K, Netea MG, van den Hoogen FHJ, Joosten LAB, den Broeder AA.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):140-143. Epub 2017 Oct 18.

PMID:
29148425
46.

Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab.

Tweehuysen L, van den Bemt BJF, van Ingen IL, de Jong AJL, van der Laan WH, van den Hoogen FHJ, den Broeder AA.

Arthritis Rheumatol. 2018 Jan;70(1):60-68. doi: 10.1002/art.40324. Epub 2017 Dec 7.

47.

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Johnson SR, Soowamber ML, Fransen J, Khanna D, Van Den Hoogen F, Baron M, Matucci-Cerinic M, Denton CP, Medsger TA Jr, Carreira PE, Riemekasten G, Distler J, Gabrielli A, Steen V, Chung L, Silver R, Varga J, Müller-Ladner U, Vonk MC, Walker UA, Wollheim FA, Herrick A, Furst DE, Czirjak L, Kowal-Bielecka O, Del Galdo F, Cutolo M, Hunzelmann N, Murray CD, Foeldvari I, Mouthon L, Damjanov N, Kahaleh B, Frech T, Assassi S, Saketkoo LA, Pope JE.

Scand J Rheumatol. 2018 Jan;47(1):62-70. doi: 10.1080/03009742.2017.1299793. Epub 2017 Oct 9.

PMID:
28990485
48.

Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial.

den Broeder AA, Verhoef LM, Fransen J, Thurlings R, van den Bemt BJF, Teerenstra S, Boers N, den Broeder N, van den Hoogen FHJ.

Trials. 2017 Aug 30;18(1):403. doi: 10.1186/s13063-017-2134-x.

49.

Patient Acceptable Symptom State in Knee Osteoarthritis Patients Succeeds Across Different Patient-reported Outcome Measures Assessing Physical Function, But Fails Across Other Dimensions and Rheumatic Diseases.

Mahler EAM, Boers N, Bijlsma JWJ, van den Hoogen FHJ, den Broeder AA, van den Ende CHM.

J Rheumatol. 2018 Jan;45(1):122-127. doi: 10.3899/jrheum.170181. Epub 2017 Aug 15.

PMID:
28811352
50.

Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma.

van Boxtel W, Boon E, Weijs WLJ, van den Hoogen FJA, Flucke UE, van Herpen CML.

Oral Oncol. 2017 Sep;72:198-200. doi: 10.1016/j.oraloncology.2017.06.023. Epub 2017 Jun 30. No abstract available.

Supplemental Content

Loading ...
Support Center